COLLEEN SCOTTON: Open Payments
NPI 1619368040 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 45 payments from 10 companies in 2025. Trend: 2023 $6,479 · 2024 $1,233 · 2025 $1,506
Food & beverage: $1,417Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $788 |
| ABBVIE INC. | 15 | $284 |
| Ipsen Biopharmaceuticals, Inc | 3 | $98 |
| Lilly USA, LLC | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Janssen Scientific Affairs, LLC | 2 | $44 |
| Veloxis Pharmaceuticals, Inc. | 1 | $37 |
| QOL Medical, LLC | 1 | $33 |
| PFIZER INC. | 1 | $29 |
| GENZYME CORPORATION | 1 | $24 |
Products named: TREMFYA, RINVOQ, SKYRIZI, IQIRVO, ENTYVIO, OMVOH, MOUNJARO, ENVARSUS.
Industry payments across NY — which companies pay providers there.
